Paper Details

  1. Home
  2. Paper Details

Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.

Author: CraigTimothy J, FishJames E, KarpelJill P, KerwinEdward, LumryWilliam, LutskyBarry, NayakAnjuli

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Mometasone furoate delivered by HFA-227 metered dose inhaler significantly reduces daily oral corticosteroid use and facilitates elimination of oral corticosteroid use in patients with severe persistent asthma.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: The reduction of oral prednisone use by mometasone furoate (MF) delivered by HFA-227 metered dose inhaler (MDI) was examined in oral corticosteroid (OCS)-dependent patients with severe persistent asthma. METHODS: A 3-month, double-blind, placebo-controlled clinical trial (n=123), followe...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.rmed.2006.06.005

データ提供：米国国立医学図書館（NLM）

Inhaled Mometasone Furoate: A Potential Solution for Severe Asthma

Severe persistent asthma, like a desert storm, can wreak havoc on the lungs. This study, like a well-equipped caravan navigating a challenging journey, explores the potential of inhaled mometasone furoate (MF) to improve the lives of patients with this chronic condition.

Mometasone Furoate: A Promising Therapy for Severe Asthma

The researchers, like skilled artisans crafting a solution, conducted a double-blind, placebo-controlled clinical trial involving patients with severe persistent asthma who were dependent on oral corticosteroids. The study assessed the efficacy of MF in reducing oral corticosteroid (OCS) usage and improving lung function.

Breathing Easier: Mometasone Furoate's Benefits for Asthma Patients

This research, like a refreshing oasis in a parched desert, offers hope for patients struggling with severe asthma. The findings suggest that inhaled MF can significantly reduce OCS usage and improve lung function, providing a more manageable approach to managing this chronic condition.

Dr. Camel's Conclusion

This study highlights the potential of inhaled mometasone furoate as an effective treatment for severe persistent asthma. By reducing reliance on oral corticosteroids and improving lung function, this medication could significantly enhance the quality of life for patients with this chronic condition.
Date :
  1. Date Completed 2007-04-23
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

16875813

DOI: Digital Object Identifier

10.1016/j.rmed.2006.06.005

Related Literature

Article Analysis
・Effects of mometasone oral inhalation
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.